Latest BioArctic News & Updates
See the latest news and media coverage for BioArctic. We track all announcements, press releases, and industry mentions in real time, all in one place.
Research-oriented biopharma company for neurodegenerative diseases
bioarctic.com- Headquarters
- Stockholm, Sweden
- Founded year
- 2003
- Company type
- Public company
- Number of employees
- 125–200
Latest news about BioArctic
Company announcements
-
BioArctic receives EUR 20 million milestone payment
Leqembi global sales exceeded EUR 500 million in Eisai’s fiscal year 2025 and BioArctic is preparing joint Nordic commercialization.
-
BioArctic reports Leqembi sales of JPY 26.2 billion
The sales generate SEK 161 million in royalties for BioArctic, about a 68% increase versus the first quarter 2025.
-
BioArctic ranks in Europe's top 10 biotechs
It joins other Swedish and Nordic success stories.
-
BioArctic convenes Annual General Meeting on May 28, 2026
The notice outlines participation rules, agenda including financial approvals, board elections, dividend of SEK 2 per share, incentive program, and remuneration guidelines.
Media coverage
-
161 million in royalty for Bioarctic during the quarter
The pharmaceutical company Bioarctic received preliminarily a royalty of 161 million kronor regarding the sales for Leqembi for the first quarter of 2026, according to...
-
Goldman cuts BioArctic on valuation, competitive risks from Eli Lilly; shares down
BioArctic shares fell about 5% on Tuesday after Goldman Sachs cut the stock to "neutral" from "buy," saying recent gains have narrowed upside to its...
-
BioArctic publishes the Annual Report and Sustainability Report for 2025
STOCKHOLM, April 21, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that the Annual Report for 2025 has been published and is...
-
Stockholm Stock Exchange turns up - Bioarctic falls after new setback
Stockholm Stock Exchange started Friday with slightly sour movements but is now trading up. At 12.00 it looks like this: • OMXSPI: +0.6% • OMXS30: +0.3% S&P...
Track BioArctic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
BioArctic competitors & trending companies
Browse news for competitors to BioArctic and other trending companies.
Clene
Annexon Biosciences
Transposon Therapeutics
Prilenia Therapeutics
Origami Therapeutics
Tiziana Life Sciences
Revalesio
QurAlis
AlzeCure Pharma
Alzinova
Herantis Pharma
VectorY Therapeutics
NRG Therapeutics
NeuroSense Therapeutics
Harness Therapeutics
Dunad Therapeutics
AL-S Pharma
Neurimmune
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish